HPE
44
-2
URBN
48
-6
MMM
35
-5
URI
60
-6
T
48
3
BA
47
2
R
70
-3
ADM
28
3
NAVI
52
-2
M
31
-3
CB
57
2
GS
72
4
KMX
61
-3
SPG
60
2
D
40
2
PCAR
56
-5
GILD
47
-8
BMY
55
-8
EXPD
43
-4
SYF
86
-6
HPE
44
-2
URBN
48
-6
MMM
35
-5
URI
60
-6
T
48
3
BA
47
2
R
70
-3
ADM
28
3
NAVI
52
-2
M
31
-3
CB
57
2
GS
72
4
KMX
61
-3
SPG
60
2
D
40
2
PCAR
56
-5
GILD
47
-8
BMY
55
-8
EXPD
43
-4
SYF
86
-6
Financhill
Back

Protagonist Therapeutics Vs. Repligen Industry Stock Comparison

Sell
26

PTGX
Protagonist Therapeutics

Last Price:
41.14
Seasonality Move:
12.96%
Sell
30

RGEN
Repligen

Last Price:
124.90
Seasonality Move:
7.3%
Sell
26
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $41.11. The Score for PTGX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Repligen (RGEN) is a Sell

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $124.73. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $41.11
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing slight buying pressure.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $124.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.79 Sell
Relative Strength Index (14 RSI): 31.67 Sell
Chaikin Money Flow: 434003 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.11 - 48.03) Sell
Bollinger Bands (100): (37.47 - 46.31) Sell

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 36.22 Sell
Chaikin Money Flow: -1285419 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (134.94 - 146.38) Sell
Bollinger Bands (100): (130 - 153.64) Sell

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.49 Sell
20-day SMA: 45.93 Sell
50-day SMA: 45.52 Sell
200-day SMA: 35.41 Buy
8-day EMA: 43.6 Sell
20-day EMA: 45.02 Sell
50-day EMA: 44.54 Sell
200-day EMA: 36.64 Buy

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 142.02 Sell
20-day SMA: 140.23 Sell
50-day SMA: 141.19 Sell
200-day SMA: 157.58 Sell
8-day EMA: 139.7 Sell
20-day EMA: 140.54 Sell
50-day EMA: 141.71 Sell
200-day EMA: 151.3 Sell

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.95 per share.

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):